{'Perf YTD': '36.82%', 'Index': '-', 'Current Ratio': '39.30', 'Inst Trans': '64.46%', 'Perf Quarter': '30.71%', 'Shs Float': '17.20M', 'Short Float': '1.87%', 'ATR': 'A Atara Biotherapeutics, Inc.', 'Earnings': '-', 'Income': '-28.00M', 'Inst Own': '55.30%', '52W Low': '278.88%', 'SMA20': '17.36%', 'PEG': '-', 'Avg Volume': '138.50K', 'P/C': '8.56', 'Prev Close': '34.90', 'Oper. Margin': '-', 'Target Price': '34.00', 'P/E': '-', 'Insider Trans': '4.60%', 'ROA': '-39.60%', 'Market Cap': '891.58M', 'SMA200': '45.81%', 'Beta': '-', '52W Range': '9.66 - 41.74', 'Debt/Eq': '0.00', 'Shs Outstand': '24.36M', 'EPS this Y': '66.00%', 'LT Debt/Eq': '0.00', 'Short Ratio': '2.32', 'P/FCF': '-', 'Perf Year': '-', 'Dividend': '-', 'Employees': '18', 'Change': '4.87%', 'Volatility': '12.32% 11.14%', 'Payout': '-', 'Insider Own': '1.40%', 'Rel Volume': '0.50', 'ROI': '-', '52W High': '-12.31%', 'Perf Week': '-5.62%', 'Recom': '1.70', 'Sales Q/Q1': '-', 'EPS (ttm)': '-3.00', 'EPS Q/Q': '100.00%', 'SMA50': '42.92%', 'Volume': '0.50', 'Perf Month': '74.62%', 'Cash/sh': '4.27', 'Gross Margin': '-', 'EPS past 5Y': '0.00%', 'Perf Half Y': '-', 'Quick Ratio': '39.30', 'Sales': '-', 'EPS next Q': '-0.44', 'Profit Margin': '-', 'Optionable': 'No', 'EPS next Y': '-2.65', 'Shortable': 'Yes', 'Price': '34.00', 'RSI (14)': '64.53', 'Sales past 5Y': '-'}